KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) Gross Margin (2016 - 2025)

Teladoc Health's Gross Margin history spans 12 years, with the latest figure at 114.22% for Q4 2025.

  • For Q4 2025, Gross Margin rose 10774.0% year-over-year to 114.22%; the TTM value through Dec 2025 reached 92.31%, up 3215.0%, while the annual FY2025 figure was 92.31%, 2155.0% up from the prior year.
  • Gross Margin for Q4 2025 was 114.22% at Teladoc Health, up from 70.12% in the prior quarter.
  • Across five years, Gross Margin topped out at 153.42% in Q4 2023 and bottomed at 6.48% in Q4 2024.
  • The 5-year median for Gross Margin is 71.31% (2023), against an average of 83.98%.
  • The largest annual shift saw Gross Margin crashed -14694bps in 2024 before it skyrocketed 10774bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 140.54% in 2021, then increased by 8bps to 151.43% in 2022, then grew by 1bps to 153.42% in 2023, then plummeted by -96bps to 6.48% in 2024, then soared by 1663bps to 114.22% in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Gross Margin are 114.22% (Q4 2025), 70.12% (Q3 2025), and 115.54% (Q2 2025).